Increasing Patient Diversity in Clinical Trials: Genetics, Sex & Age


We now know that individuals can vary widely in their responses to the same medication. However, the clinical trials process continues to underrepresent certain demographics in addressing the effects of that variability. The FDA has championed greater transparency to show who participated in pivotal clinical trials and stratifies the data by sex, race and age subgroups.

This symposium brings together representatives from the health system and researcher perspective, pharmaceutical industry and the FDA to share insights on the barriers and opportunities to increasing patient representation in clinical trials.

Click here for the agenda and more information.
Click here to register for this event.
Click here for directions to the Feinstein Institute for Medical Research.

Keynote Speaker: Dr. John Whyte, FDA
350 community Drive
Manhasset, NY 11030